Cargando…

Critical Role of Pathologists in the Accurate Subclassification of Non-Small Cell Lung Carcinoma (NSCLC) for Targeted Therapies: Evidence- Based Practice and the Role of IHC Markers

Detalles Bibliográficos
Autor principal:	Li, Qing Kay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926242/ https://www.ncbi.nlm.nih.gov/pubmed/29722354 http://dx.doi.org/10.4172/2476-2024.1000e105

Ejemplares similares

A pathologist-in-the-loop IHC antibody test selection using the entropy-based probabilistic method
por: Shin, Dmitriy, et al.
Publicado: (2012)

The role of pyroptosis-related genes in the diagnosis and subclassification of sepsis
por: Ding, Wencong, et al.
Publicado: (2023)

Endoscopic ultrasound with tissue sampling is accurate in the diagnosis and subclassification of gastrointestinal spindle cell neoplasms
por: Sandhu, Dalbir Singh, et al.
Publicado: (2017)

Chinese Ischemic Stroke Subclassification
por: Gao, S., et al.
Publicado: (2011)

The Evolution of Ovarian Carcinoma Subclassification
por: Köbel, Martin, et al.
Publicado: (2022)

A possible role for neutrophils in allergic rhinitis revealed after cellular subclassification
por: Arebro, Julia, et al.
Publicado: (2017)

ALK IHC and FISH discordant results in patients with NSCLC and treatment response: for discussion of the question—to treat or not to treat?
por: Cabillic, Florian, et al.
Publicado: (2018)

A practical method for accurate coordination between the plastic surgeon and the pathologist: The clockwork technique
por: Sezgin, Billur, et al.
Publicado: (2018)

The role of the pathologist in the decision-making process
por: Dei Tos, Angelo Paolo
Publicado: (2013)

Discordance between FISH, IHC, and NGS Analysis of ALK Status in Advanced Non–Small Cell Lung Cancer (NSCLC): a Brief Report of 7 Cases()
por: Scattone, Anna, et al.
Publicado: (2018)

Diagnosis and Subclassification of Acute Lymphoblastic Leukemia
por: Chiaretti, Sabina, et al.
Publicado: (2014)

Interphysician agreement on subclassification of myocardial infarction
por: Gard, Anton, et al.
Publicado: (2018)

The Importance of the Pathologist’s Role in Assessment of the Quality of the Mesorectum
por: Bosch, Steven L., et al.
Publicado: (2012)

The Role of the Toxicologic Pathologist in the Post-Genomic Era(#)
por: Maronpot, Robert R.
Publicado: (2013)

Roles of pathologists in molecular targeted cancer therapy
por: Osamura, Robert Y
Publicado: (2009)

The role of the speech language pathologist in acute stroke
por: Dilworth, Cindy
Publicado: (2008)

VEGF: A critical driver for angiogenesis and subsequent tumor growth: An IHC study
por: Kapoor, Prakhar, et al.
Publicado: (2012)

The symptomatic localization-related epilepsies: problems with subclassification.
por: Williamson, P. D.
Publicado: (1987)

Pathobiological and Radiological Approach For Hepatocellular Carcinoma Subclassification
por: Vasuri, Francesco, et al.
Publicado: (2019)

Proposal of a T3 Subclassification for Colon Carcinoma
por: Merkel, Susanne, et al.
Publicado: (2022)

Daily Practice Assessment of KRAS Status in NSCLC Patients: A New Challenge for the Thoracic Pathologist Is Right around the Corner
por: Bontoux, Christophe, et al.
Publicado: (2022)

A Sensitive IHC Method for Monitoring Autophagy-Specific Markers in Human Tumor Xenografts
por: He, Helen, et al.
Publicado: (2016)

Comparison of the IHC Markers CD138 and CD43 in Oral Leukoplakia: An Original Research
por: Akkaloori, Anitha, et al.
Publicado: (2023)

NTRK insights: best practices for pathologists
por: Hechtman, Jaclyn F.
Publicado: (2021)

Intrapatient Tumor Heterogeneity in IHC Interpretation Using PD-L1 IHC 22C3 pharmDx
por: Kalpakoff, Megan, et al.
Publicado: (2021)

The perspectives of Australian speech pathologists in providing evidence‐based practices to children with autism
por: Sandham, Victoria, et al.
Publicado: (2022)

Is Preoperative Subclassification of Type I Choledochal Cyst Necessary?
por: Jung, Kyuwhan, et al.
Publicado: (2012)

Subclassification of Newly Diagnosed Glioblastomas through an Immunohistochemical Approach
por: Conroy, Siobhan, et al.
Publicado: (2014)

Evolution and current status of the subclassification of intermediate hepatocellular carcinoma
por: Yi, Peng-Sheng, et al.
Publicado: (2020)

Development of an Automated PD-L1 Immunohistochemistry (IHC) Assay for Non–Small Cell Lung Cancer
por: Phillips, Therese, et al.
Publicado: (2015)

Diagnosing Kaposi’s Sarcoma (KS) in East Africa: how accurate are clinicians and pathologists?
por: Amerson, Erin, et al.
Publicado: (2012)

Efficacy of D5F3 IHC for detecting ALK gene rearrangement in NSCLC patients: a systematic review and meta-analysis
por: Ma, Hu, et al.
Publicado: (2016)

Editorial: Subclassification of AUS/FLUS category for thyroid nodules: trials and evidence-based clinical management
por: Bayraktaroğlu, Taner, et al.
Publicado: (2023)

Impact of COVID-19 on the practice of breast pathologists: a survey of breast pathologists in the UK and Ireland
por: Elghobashy, Mirna, et al.
Publicado: (2023)

How do surgical pathologists evaluate critical diagnoses (critical values)?
por: Mireskandari, Masoud
Publicado: (2008)

Diminutive and Small Colorectal Polyps: The Pathologist's Perspective
por: Kang, Yun Kyung
Publicado: (2014)

Subclassification of pulmonary non-small cell lung carcinoma in fine needle aspirates using a limited immunohistochemistry panel
por: Kapila, Kusum, et al.
Publicado: (2013)

Role of the Pathologist in the Diagnosis of Hereditary Non-Polyposis Colorectal Cancer
por: Jass, Jeremy R.
Publicado: (2004)

The Role of the Pathologist in the Next-Generation Era of Tumor Molecular Characterization
por: Angerilli, Valentina, et al.
Publicado: (2021)

Morphologic Spectrum of Undetermined Causes of Hemoptysis- A Pathologist’s Role
por: Ganesan, Nidhya, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_akcsneo76gp9amvt4rv21jks7r